Stromectol, containing the active ingredient ivermectin, is a prescription antiparasitic medication recognized for its broad-spectrum efficacy against a range of parasitic infections. It is widely utilized in both clinical and public health settings due to its high success rates and favorable safety profile when used as directed. This medication works by paralyzing and killing parasites, offering relief and resolution for conditions caused by susceptible organisms. Always use under medical supervision to ensure appropriate diagnosis, dosing, and monitoring.

Features

• Active ingredient: Ivermectin
• Available in 3 mg scored tablets
• Oral administration
• Manufactured under strict pharmaceutical standards
• Requires prescription
• Suitable for adults and children weighing over 15 kg

Benefits

• Effectively eliminates a variety of parasitic infections, reducing morbidity and transmission.
• Single-dose regimens are available for certain indications, supporting treatment adherence.
• Contributes to public health efforts in endemic regions by reducing parasite load in communities.
• Generally well-tolerated with a low incidence of severe adverse effects when used correctly.
• Helps alleviate symptoms such as itching, skin lesions, and visual disturbances associated with parasitic diseases.
• Supports improved quality of life and long-term health outcomes in affected individuals.

Common use

Stromectol is primarily indicated for the treatment of parasitic infections including strongyloidiasis (caused by Strongyloides stercoralis) and onchocerciasis (river blindness, caused by Onchocerca volvulus). It may also be used off-label or in combination therapies for other parasitic conditions, such as scabies or certain types of filariasis, under medical guidance. Its use is common in mass drug administration programs in regions where these infections are endemic.

Dosage and direction

Dosage is based on body weight and the specific infection being treated. For strongyloidiasis, the typical dose is 200 mcg/kg orally as a single dose. For onchocerciasis, 150 mcg/kg orally as a single dose is standard; retreatment may be required every 6 to 12 months. Tablets should be taken on an empty stomach with water. Follow healthcare provider instructions precisely; do not crush or split tablets unless advised.

Precautions

Inform your healthcare provider of any allergies, especially to ivermectin or similar medications. Use with caution in patients with liver impairment, as metabolism may be affected. Avoid use in pregnancy unless potential benefits outweigh risks—adequate contraception is advised. Breastfeeding individuals should consult a doctor before use. Not recommended for children under 5 years or weighing less than 15 kg unless specified by a physician.

Contraindications

Hypersensitivity to ivermectin or any component of the formulation. Contraindicated in patients with known or suspected Loa loa infection (unless properly managed due to risk of serious encephalopathy). Avoid in combination with certain other medications that increase blood-brain barrier permeability without medical oversight.

Possible side effect

Common side effects may include dizziness, nausea, diarrhea, pruritus, rash, or transient elevation in liver enzymes. Less frequently, orthostatic hypotension, fever, or headache may occur. Rare but serious effects include severe skin reactions, neurological events such as seizures or confusion (particularly in cases of high parasitic load), and hepatitis. Seek medical attention if severe or persistent symptoms develop.

Drug interaction

Ivermectin is a substrate of CYP3A4. Concomitant use with strong CYP3A4 inducers (e.g., rifampin, carbamazepine) may decrease ivermectin levels. Inhibitors of CYP3A4 (e.g., ketoconazole, ritonavir) may increase ivermectin concentrations. Use caution with other medications that suppress the central nervous system. Warfarin and other anticoagulants may require monitoring. Always disclose all medications, including supplements, to your prescriber.

Missed dose

If a dose is missed, take it as soon as remembered unless it is almost time for the next dose. Do not double the dose to catch up. Follow your healthcare provider’s instructions regarding missed doses, especially in the context of scheduled public health regimens.

Overdose

Overdose may manifest as exaggerated side effects, including nausea, vomiting, diarrhea, dizziness, or hypotension. In severe cases, neurological symptoms such as ataxia, respiratory depression, or coma may occur. There is no specific antidote; treatment is supportive and symptomatic. Gastric lavage and activated charcoal may be considered if ingestion was recent. Seek emergency medical attention immediately.

Storage

Store at room temperature (15–30°C or 59–86°F) in a dry place, protected from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.

Disclaimer

This information is for educational purposes and does not replace professional medical advice. Always consult a qualified healthcare provider for diagnosis, treatment decisions, and personalized recommendations. Use only as prescribed; do not self-medicate. The manufacturer and distributor are not liable for misuse or incorrect application of this information.

Reviews

Stromectol has been extensively studied and is endorsed by global health organizations for its efficacy in treating parasitic diseases. Clinical trials and real-world use demonstrate high cure rates and patient tolerance. In endemic areas, it has significantly reduced disease burden and improved community health outcomes. Individual experiences vary; always discuss treatment benefits and risks with your healthcare provider.